Neuroprotective effects of the ethanol stem bark extracts of Terminalia ivorensis in ketamine-induced schizophrenia-like behaviors and oxidative damage in mice

References

• Adiko VA, Barthelemy KA, Félix ZT, Kouamé MA, Coulibali S, Léon AD. 2013. Separation and characterization of phenolic compounds from Terminalia ivoiriensis using liquid chromatography-positive electrospray ionization tandem mass spectroscopy. Afr J Biotechnol. 12:4393–4398.
   Google Scholar
• Agbedahunsi JM, IvieAnao CO, Clement OA, Simon LC. 2006. Trypanocidal properties of terminalia ivorensis. Chevalier (Combretaceae). Afr J Tradit Complement Altern Med. 3:51–56.
   Google Scholar
• Aguirre-Hernandez E, Gonzalez-Trujano ME, Martinez AL, Moreno J, Kite G, Terrazas T, Soto-Hernandez M. 2010. HPLC/MS and anxiolytic-like effect of quercetin and kaemferol flavonoids from Tilia americana var. maxicana. J Ethnopharmacol. 127:91–97.
   PubMed Web of Science ®Google Scholar
• Andreasen NC. 1990. Methods for assessing positive and negative symptoms of schizophrenia. Mod Probl Pharmacopsychiatry. 24:73–88.
   PubMedGoogle Scholar
• Aoyama K, Suh SW, Hamby AM, Liu J, Chan WY, Chen Y, Swanson RA. 2006. Neuronal glutathione deficiency and age-dependent neurodegeneration in the EAAC1 deficient mouse. Nat Neurosci. 9:119–126.
   PubMed Web of Science ®Google Scholar
• Arnt J, Skarsfeldt T. 1998. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology. 18:63–101.
   PubMed Web of Science ®Google Scholar
• Aultman JM, Moghaddam B. 2001. Distinct contributions of glutamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task. Psychopharmacology (Berl). 153:353–364.
   PubMed Web of Science ®Google Scholar
• Becker A, Grecksch G. 2004. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity. Prog Neuropsychopharmacol Biol Psychiatry. 28:1267–1277.
   PubMed Web of Science ®Google Scholar
• Behrens MM, Ali SS, Dugan LL. 2008. Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia. J Neurosci. 28:13957–13966.
   PubMed Web of Science ®Google Scholar
• Behrens MM, Sejnowski TJ. 2009. Does schizophrenia arise from oxidative dysregulation of parvalbumininterneurons in the developing cortex? Neuropharmacol. 57:193–200.
   PubMed Web of Science ®Google Scholar
• Benturquia N, Courtin C, Noble F, Marie-Claire C. 2008. Involvement of D1 dopamine receptor in MDMA-induced locomotor activity and striatal gene expression in mice. Brain Res.1211:1–5.
   PubMed Web of Science ®Google Scholar
• Bitanihirwe KY, Tsung-Ung W, Woo MD. 2011. Oxidative stress in schizophrenia: An integrated approach. Neurosci Biobehav Rev. 35:878–893.
   PubMed Web of Science ®Google Scholar
• Bókkon I, Antal I. 2011. Schizophrenia: redox regulation and volume neurotransmission. Curr Neuropharmacol. 9:289–300.
   PubMed Web of Science ®Google Scholar
• Bourin M, Poisson L, Larousse C. 1986. Piracetam interaction with neuroleptics in psychopharmacological tests. Neuropsychobiology. 19:93–96.
   Google Scholar
• Buckley PF, Stahl SM. 2007. Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac? Acta Psychiatr Scand. 115:93–100.
   PubMed Web of Science ®Google Scholar
• Chatterjee M, Ganguly S, Srivastava M, Palit G. 2011. Effect of ‘chronic’ versus ‘acute’ ketamine administration and its ‘withdrawal’ effect on behavioural alterations in mice: implications for experimental psychosis. Behav Brain Res. 216:247–254.
   PubMed Web of Science ®Google Scholar
• Chatterjee M, Rajkumar V, Surajit G, Gautam P. 2012. Neurochemical and molecular characterization of ketamine-induced experimental psychosis model in mice. Neuropharmacology. 63:1161–1171.
   PubMed Web of Science ®Google Scholar
• Coates KM, Flood P. 2001. Ketamine and its preservative, benzethonium chloride, both inhibit human recombinant alpha7 and alpha4beta2 neuronal nicotinic acetylcholine receptors in Xenopus oocytes. Br J Pharmacol. 134:871–879.
   PubMed Web of Science ®Google Scholar
• Coulibaly K, Zirihi GN, N'Guessan K, Djaman AJ. 2006. Botanical study and evaluation of antifungal activity of Terminalia ivorensis and Terminalia superba (Combretaceae) on the growth in vitro of Aspergillus fumigatus. Int J Ph Sci. 2:904–912.
   Google Scholar
• Dall’igna OP, Fett P, Gomes MW. 2007. Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice . Exp Neurol. 203:241–245.
   PubMed Web of Science ®Google Scholar
• De Oliveira L, Spiazzi CM, Bortolin T. 2009. Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats. Prog Neuropsychopharmacol Biol Psychiatry. 33:1003–1008.
   PubMed Web of Science ®Google Scholar
• Do KQ, Cabungcal JH, Frank A, Steullet P, Cuenod M. 2009. Redox dysregulation, neurodevelopment, and schizophrenia. Curr Opin Neurobiol. 19:220–230.
   PubMed Web of Science ®Google Scholar
• Dodd S, Dean O, Copolov DL, Malhi GS, Berk M. 2008. N-Acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opin Biol Ther. 8:1955–1962.
   PubMed Web of Science ®Google Scholar
• Foli EG. (2009). Terminalia ivorensis A. Chevalier. In: Lemmens RHMJ, Louppe D, OtengAmoako A, editors. Prota 7(2): Timbers/Bois d’œuvre 2. [CD-Rom]. PROTA, Wageningen: Netherlands.
   Google Scholar
• Freedman R. 2003. Schizophrenia. N Engl J Med. 349:1738–1749.
   PubMed Web of Science ®Google Scholar
• Geyer MA, Moghaddam B. 2002. Animal models relevant to schizophrenia disorders. Neuropsychopharmacology. 50:690–701.
   Google Scholar
• Gornall AG, Bardawill CJ, David MM. 1949. Determination of serum proteins by means of the biuret reaction. J Biol Chem. 177:751–766.
   PubMed Web of Science ®Google Scholar
• Halliwell B. 2006. Oxidative stress and neurodegeneration: where are we now? J Neurochem. 97:1634–1658.
   PubMed Web of Science ®Google Scholar
• Hasselmo ME. 2006. The role of acetylcholine in learning and memory. Curr Opin Neurobiol. 16:710–715.
   PubMed Web of Science ®Google Scholar
• Himi T, Ikeda M, Yasuhara T. 2003. Oxidative neuronal death caused by glutamate uptake inhibition in cultured hippocampal neurons. J Neurosci Res. 71:679–688.
   PubMed Web of Science ®Google Scholar
• Ikonomidou C, Kaindl AM. 2011. Neuronal death and oxidative stress in the developing brain. Antioxid Redox Signal. 14:1535–1550.
   PubMed Web of Science ®Google Scholar
• Irifune M, Shimizu T, Nomoto M. 1991. Ketamine-induced hyperlocomotion associated with alteration of presynaptic component of dopamine neurons in the nucleus accumbens of mice. Pharmacol Biochem Behav. 40:399–407.
   PubMed Web of Science ®Google Scholar
• Iwu MM, Anyawu BN. 1982. Anti-inflammatory and anti-arthritic properties of Terminalia ivorensis. Fitoterapia. 52:25–34.
   Google Scholar
• Janaky R, Dohovics R, Saransaari P. 2007. Modulation of [3H]dopamine release by glutathione in mouse striatal slices. Neurochem Res. 32:1357–1364.
   PubMed Web of Science ®Google Scholar
• Javitt DC, Grochowski S, Shelley AM, Ritter W. 1998. Impaired mismatch negativity (MMN) generation in schizophrenia as a function of stimulus deviance, probability, and interstimulus/interdeviant interval. Electroencephalogr Clin Neurophysiol. 108:143–153.
   PubMedGoogle Scholar
• Jentsch JD, Roth RH. 1999. The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology. 20:201–225.
   PubMed Web of Science ®Google Scholar
• Jollow DJ, Michell JR, Zampaglione N, Gillete J. 1974. Bromobenzene-induced liver necrosis. Protective role of glutathione an evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology. 11:151–169.
   PubMed Web of Science ®Google Scholar
• Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD. 1994. Subanaesthetic effects of the non-competitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry. 51:199–214.
   PubMed Web of Science ®Google Scholar
• Lahti AC, Koffel B, LaPorte D, Tamminga CA. 1995. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology. 13:9–19.
   PubMed Web of Science ®Google Scholar
• Larson MK, Walker EF, Compton MT. 2010. Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders. Expert Rev Neurother. 10:1347–1359.
   PubMed Web of Science ®Google Scholar
• Lavoie S, Murray MM, Deppen P. 2008. Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients. Neuropsychopharmacology. 33:2187–2199.
   PubMed Web of Science ®Google Scholar
• Lawal IO, Uzokwe NE, Igboanugo AB, Adio AF, Awosan EA, Nwogwugwu JO. 2010. Ethno-medicinal information on collation and identification of some medicinal plants in Research Institutes of South-west Nigeria. Afr J Pharm Pharmacol. 4:001–007.
   Web of Science ®Google Scholar
• Lorke D. 1983. A new approach to practical acute toxicity testing. Arch Toxicol. 54:275–287.
   PubMed Web of Science ®Google Scholar
• Lorrain DS, Baccei CS, Bristow LJ. 2003. Effects of ketamine and N-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropicglutamate receptor agonist LY379268. Neuroscience. 117:697–706.
   PubMed Web of Science ®Google Scholar
• Mahadik SP, Evans D, Lal H. 2001. Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 25:463–493.
   PubMed Web of Science ®Google Scholar
• Malcom SA, Sofowora EA. 1969. Antimicrobial activity of selected Niegerian folk remedies and their constituent plants. Lloydia. 32:512–517.
   PubMedGoogle Scholar
• Misra HP, Fridovich I. 1972. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 247:3170–3175.
   PubMed Web of Science ®Google Scholar
• Monji A, Kato T, Kanba S. 2009. Cytokines and schizophrenia: microglia hypothesis of schizophrenia. Psychiatry Clin Neurosci. 63:257–265.
   PubMed Web of Science ®Google Scholar
• Monte AS, Greicy CS, Roger SM, Joanna KS, Júnia VS, Rafaela CC. 2013. Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: possible involvement of antioxidant and nitrergic pathway. J Psychopharmacol. 11:1032–1043.
   Web of Science ®Google Scholar
• Mouri A, Noda Y, Noda A, Nakamura T, Tokura T, Yura Y, Nitta A, Furukawa H, Nabeshima T. 2007. Involvement of a dysfunctional sopamine-D1/N-methyl-d-aspartate- NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine. Mol Pharmacol. 71:1598–1609.
   PubMed Web of Science ®Google Scholar
• Oja SS, Janáky R, Varga V, Saransaari P. 2000. Modulation of glutamate receptor functions by glutathione. Neurochem Int. 37:299–306.
   PubMed Web of Science ®Google Scholar
• Okhawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 95:351–358.
   PubMed Web of Science ®Google Scholar
• Omogbiya IA, Solomon U, Aderibigbe AO, Adewale GB. 2013. Jobelyn pretreatment ameliorates symptoms of psychosis in experimental models. J Basic Clin Physiol Pharmacol. 24:331–336.
   PubMedGoogle Scholar
• Pavlovic D, Tamburic V, Stojanovic I. 2002. Oxidative stress as marker of positive symptoms in schizophrenia. Facta Univ. 9:157–161.
   Google Scholar
• Pazvantoglu O, Selek S, Okay IT. 2009. Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile. Psychiatry Clin Neurosci. 63:693–700.
   PubMed Web of Science ®Google Scholar
• Picchioni MM, Murray RM. 2007. Schizophrenia. BMJ. 335:91–95.
   PubMed Web of Science ®Google Scholar
• Ponou BK, Teponno RB, Ricciutelli M, Quassinti L, Bramucci M, Lupidi G, Barboni L, Tapondjou LA. 2010. Dimeric antioxidant and cytotoxic triterpenoid saponins from Terminalia ivorensis A. Chev. Phytochemistry. 71:2108–2115.
   PubMed Web of Science ®Google Scholar
• Rujescu D, Bender A, Hartmann AM, Ohl F, Raeder H. 2006. A pharmacological model of psychosis based on N methyl-d-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities. Biol Psychiatry. 59:721–729.
   PubMed Web of Science ®Google Scholar
• Sallmann S, Juttler E, Prinz S, Petersen N, Knopf U, Weiser T, Schwaninger M. 2000. Induction of interleukin-6 by depolarization of neurons. J Neurosci. 20:8637–8642.
   PubMed Web of Science ®Google Scholar
• Seamans JK, Yang CR. 2004. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol. 74:1–58.
   PubMed Web of Science ®Google Scholar
• Singh RP, Sharad S, Kapur S. 2004. Free radicals and oxidative stress in neurodegenerative diseases: relevance of dietary antioxidants. JIACM. 5:218–225.
   Google Scholar
• Sinha KA. 1971. Colorimetric assay of catalase. Anal Biochem. 47:389–394.
   Web of Science ®Google Scholar
• Sorce S, Schiavone S, Tucci P, Colaianna M, Jaquet V, Cuomo V, Dubois-Dauphin M, Trabace L, Krause KH. 2010. The NADPH oxidase NOX2 controls glutamate release: a novel mechanism involved in psychosis-like ketamine responses. J Neurosci. 30:11317–11325.
   PubMed Web of Science ®Google Scholar
• Steullet P, Neijt HC, Cuénod M, Do KQ. 2006. Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia. Neuroscience. 137:807–819.
   PubMed Web of Science ®Google Scholar
• Swerdlow NR, Braff DL, Taaid N, Geyer MA. 1994. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry. 51:139–154.
   PubMed Web of Science ®Google Scholar
• Turetsky BI, Calkins ME, Light GA, Olincy A, Radant AD, Swerdlow NR. 2007. Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr Bull. 33:69–94.
   PubMed Web of Science ®Google Scholar
• Umbricht D, Schmid L, Koller R, Vollenweider FX, Hell D, Javitt DC. 2000. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: Implications for models of cognitive deficits in schizophrenia. Arch Gen Psychiatry. 57:1139–1147.
   PubMed Web of Science ®Google Scholar
• Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. 2007. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 39:44–84.
   PubMed Web of Science ®Google Scholar
• Varga V, Jenei Z, Janaky R. 1997. Glutathione is an endogenous ligand of rat brain N-methyl-a-aspartate (NMDA) and 2-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors. Neurochem Res. 22:1165–1171.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang H, Yuan Q. 2013. Purification, antioxidant activity and protein-precipitating capacity of punicalin from pomegranate husk. Food Chem. 138:437–443.
   PubMed Web of Science ®Google Scholar
• Wood SJ, Yücel M, Pantelis C, Berk M. 2009. Neurobiology of schizophrenia spectrum disorders: the role of oxidative stress. Ann Acad Med Singapore. 38:396–396.
   PubMed Web of Science ®Google Scholar
• Yamada K, Noda Y, Hasegawa T, Komori Y, Nikai T, Sugihara H, Nabeshima T. 1996. The role of nitric oxide in dizocilpine-induced impairment of spontaneous alternation behavior in mice. J Pharm Exp Ther. 276:460–466.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Behrens MM, Lisman JE. 2008. Prolonged exposure to NMDAR antagonist suppresses inhibitory synaptic transmission in prefrontal cortex. J Neurophysiol. 100:959–965.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhao Z, He L, Wan C. 2010. A meta-analysis of oxidative stress markers in schizophrenia. Sci China Life Sci. 53:112–124.
   PubMed Web of Science ®Google Scholar
• Zijia Z, Liping L, Jeffrey M, Tao W, Zhengtao W. 2009. Antioxidant phenolic compounds from walnut kernels (Juglansregia L). Food Chem. 113:160–165.
   Web of Science ®Google Scholar